A.O.M. Stoppani

5.6k total citations · 2 hit papers
168 papers, 4.6k citations indexed

About

A.O.M. Stoppani is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, A.O.M. Stoppani has authored 168 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 40 papers in Epidemiology and 39 papers in Organic Chemistry. Recurrent topics in A.O.M. Stoppani's work include Trypanosoma species research and implications (39 papers), Synthesis and Biological Evaluation (23 papers) and Enzyme function and inhibition (21 papers). A.O.M. Stoppani is often cited by papers focused on Trypanosoma species research and implications (39 papers), Synthesis and Biological Evaluation (23 papers) and Enzyme function and inhibition (21 papers). A.O.M. Stoppani collaborates with scholars based in Argentina, United States and Brazil. A.O.M. Stoppani's co-authors include Enrique Cadenas, Alberto Boveris, A Boveris, Roberto Docampo, C I Ragan, Juan José Cazzulo, Marta Dubin, Julio F. Turrens, Juan C. Vidal and Alberto C.C. Frasch and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

A.O.M. Stoppani

166 papers receiving 4.4k citations

Hit Papers

Production of superoxide radicals and hydrogen peroxide b... 1976 2026 1992 2009 1977 1976 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.O.M. Stoppani Argentina 34 2.6k 1.2k 894 690 614 168 4.6k
R. Heiner Schirmer Germany 49 4.3k 1.7× 602 0.5× 1.1k 1.3× 1.9k 2.7× 391 0.6× 104 7.6k
Ernest Bueding United States 47 2.5k 1.0× 248 0.2× 562 0.6× 316 0.5× 300 0.5× 165 6.2k
Lars Gille Austria 35 1.8k 0.7× 460 0.4× 739 0.8× 523 0.8× 422 0.7× 127 4.5k
Carol A. Rouzer United States 41 3.1k 1.2× 359 0.3× 1.0k 1.2× 177 0.3× 1.9k 3.2× 79 8.4k
Romana Fato Italy 43 3.7k 1.4× 334 0.3× 700 0.8× 174 0.3× 820 1.3× 110 5.7k
Gonzalo Peluffo Uruguay 26 1.1k 0.4× 801 0.7× 431 0.5× 658 1.0× 1.0k 1.7× 36 3.3k
Jeffrey Grove France 37 3.4k 1.3× 245 0.2× 312 0.3× 353 0.5× 372 0.6× 93 5.6k
Antonio Macho Spain 29 4.1k 1.6× 501 0.4× 331 0.4× 137 0.2× 420 0.7× 68 6.4k
Pallu Reddanna India 40 2.4k 0.9× 243 0.2× 887 1.0× 216 0.3× 342 0.6× 190 5.9k
T Schewe Germany 38 2.0k 0.8× 155 0.1× 987 1.1× 129 0.2× 733 1.2× 125 5.2k

Countries citing papers authored by A.O.M. Stoppani

Since Specialization
Citations

This map shows the geographic impact of A.O.M. Stoppani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.O.M. Stoppani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.O.M. Stoppani more than expected).

Fields of papers citing papers by A.O.M. Stoppani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.O.M. Stoppani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.O.M. Stoppani. The network helps show where A.O.M. Stoppani may publish in the future.

Co-authorship network of co-authors of A.O.M. Stoppani

This figure shows the co-authorship network connecting the top 25 collaborators of A.O.M. Stoppani. A scholar is included among the top collaborators of A.O.M. Stoppani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.O.M. Stoppani. A.O.M. Stoppani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paulino, Margot, et al.. (2005). The Chemotherapy of Chagas Disease: An Overview. Mini-Reviews in Medicinal Chemistry. 5(5). 499–519. 71 indexed citations
2.
Stoppani, A.O.M., et al.. (2004). 2-Phenyl-β-lapachone can affect mitochondrial function by redox cycling mediated oxidation. Archives of Biochemistry and Biophysics. 432(2). 129–135. 29 indexed citations
3.
Cannata, Joaquı́n J.B., et al.. (2004). Purification and properties of poly(ADP-ribose)polymerase from Crithidia fasciculata. Molecular and Biochemical Parasitology. 135(2). 211–219. 8 indexed citations
4.
Stoppani, A.O.M., et al.. (2003). Inactivation ofTrypanosoma cruziandCrithidia fasciculatatopoisomerase I by Fenton systems. Redox Report. 8(6). 357–363. 4 indexed citations
5.
Krauth‐Siegel, R. Luise, et al.. (2003). Phenothiazine Radicals Inactivate Trypanosoma cruzi Dihydrolipoamide Dehydrogenase: Enzyme Protection by Radical Scavengers. Free Radical Research. 37(3). 281–291. 14 indexed citations
6.
Dubin, Marta, et al.. (2001). Citotoxicidad de la beta-lapachona: una orto-naftoquinona con posibles usos terapéuticos. 79. 81–99. 1 indexed citations
7.
Fairlamb, Alan H., et al.. (2001). Trypanosoma Cruzitrypanothione reductase is inactivated by peroxidase-generated phenothiazine cationic radicals. Free Radical Research. 34(4). 363–378. 38 indexed citations
8.
Dubin, Marta, et al.. (1997). Semiquinone production by lipophilico-naphthoquinones. Redox Report. 3(4). 245–252. 4 indexed citations
9.
Stoppani, A.O.M., et al.. (1996). Redox cycling of o-naphthoquinones in yrypanosomatids. Biochemical Pharmacology. 52(12). 1875–1882. 55 indexed citations
10.
Stoppani, A.O.M., et al.. (1993). Effect of polyamines on mitochondrial F-ATPase from Crithidia fasciculata and Trypanosoma cruzi.. PubMed. 29(1). 131–9. 1 indexed citations
11.
Stoppani, A.O.M., et al.. (1992). Electronic Properties and Free Radical Production by Nitrofuran Compounds. Free Radical Research Communications. 16(4). 207–215. 5 indexed citations
12.
Dubin, Marta, et al.. (1991). Inhibition of Microsomal Lipid Peroxidation and Cytochrome P-450-Catalyzed Reactions by Nitrofuran Compounds. Free Radical Research Communications. 14(5-6). 419–431. 9 indexed citations
13.
Dubin, Marta, et al.. (1990). Effects of mansonones on lipid peroxidation, P450 monooxygenase activity, and superoxide anion generation by rat liver microsomes. Biochemical Pharmacology. 40(10). 2343–2351. 14 indexed citations
14.
Dubin, Marta, et al.. (1990). Inhibition of microsomal lipid peroxidation and cytochrome P-450-catalyzed reactions by β-lapachone and related naphthoquinones. Biochemical Pharmacology. 39(7). 1151–1160. 31 indexed citations
15.
Stoppani, A.O.M., et al.. (1989). Nitrofuran inhibition of yeast and rat tissue glutathione reductases. Biochemical Pharmacology. 38(5). 767–772. 22 indexed citations
16.
Turrens, Julio F., et al.. (1984). [Inhibition of growth and macromolecular biosynthesis in Trypanosoma cruzi by natural products. Effects of miconidine and tingenone].. PubMed. 44(4). 361–70. 9 indexed citations
17.
Moreno, Silvia N.J., et al.. (1983). Sobre efectos indeseables del benznidazol y el nifurtimox.. Medicina-buenos Aires. 1 indexed citations
18.
Bacila, Metry, et al.. (1978). Biochemistry and genetics of yeasts : pure and applied aspects : proceedings of the symposium held at the Universidade de São Paulo, Brazil, December 4-10, 1977. Academic Press eBooks. 2 indexed citations
19.
Boveris, A, Roberto Docampo, Julio F. Turrens, & A.O.M. Stoppani. (1977). [Effect of beta and alpha-lapachone on the production of H202 and on the growth of Trypanosoma cruzi].. PubMed. 9(2). 54–61. 3 indexed citations
20.
Stoppani, A.O.M., et al.. (1969). Phosphorylation, Oxidation, and Ubiquinone Content in Diabetic Mitochondria. Experimental Biology and Medicine. 132(1). 171–174. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026